Corporate announcements

Statement of utilisation of Issue Proceeds and Statement of material deviations and variations as per Regulation 52(7) and 52(7A) of SEBI Listing Regulations for the quarter ended September 30, 2026

Intimation under Regulation 54 of SEBI (LODR) Regulations, 2015 for the quarter ended 30th September 2026.

Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026.

Gammon India Limited has informed the Exchange regarding 'In􀆟ma􀆟on of Board Mee􀆟ng of Gammon India Limited ( the Company ) to be held on Friday,6th November, 2026.'.

The Company has appointed Ms. Bhavisha Kakwani as the Company Secretary and Compliance Officer of the Company with effect from 03rd November 2026.

Disclosure regarding Continuation of Mr. Mohd Javed Qureshi as Nodal and Grievance Redressal Officer pursuant to Regulation 30 part A of Sechdule III of SEBI (LODR) Regulations, 2015

Result- Unaudited Financials as on 30.09.2026

Unaudited financial results (standalone and consolidated) of Asit C Mehta Financial Services Limited for the quarter and half year ended September 30, 2026

Global Health Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press release for the Results of Second Quarter & Half Year ended September 30, 2026."

Meyer Apparel Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the unaudited financial results for Quarter and Half Year ended September 30, 2026

TRADING WINDOW CLOSURE PARTICULARS

TRADING WINDOW CLOSURE PARTICULARS

Board of Director approved Unaudited Financial results for the quarter and half year ended 30th September, 2026 in its meeting held on 3rd November, 2026.

Awfis Space Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

To approve unaudited Financial Results for quarter and half year ended September 30, 2026

ACC Limited has informed the Exchange about Transcript of earning call held on October 29, 2026, pertaining to Unaudited financial results of the company for quarter and half year ended September 30, 2026

Wealth First Portfolio Managers Limited has informed the Exchange about Investor Presentation

Transcript of Q2-H1 2026-27 earnings conference call held on 29-10-2026

Pioneer Embroideries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 11th November, 2026 at the Unit No. 101B, 1st Floor, Abhishek Premises, Plot No. C5-6, Dalia Industrial Estate, Off New Link Road, Andheri (West), Mumbai - 400058 inter-alia to consid

Sumeet Industries Limited has submitted to the Exchange, the Un-Audited financial results for the period ended September 30, 2026.

Intimation regarding change in the Corporate Office of Registrar and Share Transfer Agent (RTA) of Company with effect from December 01, 2026.

Pursuant to Regulation 51 read with Part B of Schedule III of SEBI LODR, 2015 the Board of Directors of the Company at its meeting held today i.e. November 03, 2026 has considered and approved the Unaudited Financial Results and the Limited Review Report for the Quarter and Half year ended September 30, 2026.

N R Agarwal Industries Limited has submitted to the Exchange about the Un-audited financial results for the quarter and half year ended September 30, 2026

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Re-appointment of Mr. Ashish Mehrotra as the Managing Director and Chief Executive Officer of the Company

Unaudited Result for September 30,2026

Financial Results for the Quarter and Half Year ended 30th September 2026.

Unaudited Financial Result

VSD Confin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter and half year ended 30th September, 2026.

Capri Global Capital Limited has informed the Exchange regarding 'Revised ALM Reporting - September 2026 for Debt Listed on BSE.'

The Board of Directors of the company in its meeting held today i.e., on Tuesday, November 3, 2026 has considered and approved: 1. The Un-audited Financial Results (Standalone and Consolidated) along with Limited Review Report of the Company for the second quarter and the half year ended on September 30, 2026. 2. The approval of Code of practices and procedures for fair Disclosure of UPSI.

unaudited financial results for second quarter of financial year 2026-2027

Re-appointment of Sri K Balakrishnan as a Non-Executive Independent Director for a second term of five consecutive year from May 25, 2027 to May 24, 2032.

Intimation of Board Meeting under regulation 50 (1) of SEBI (LODR) Regulations, 2015

Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Standalone And Consolidated Financial Results of The Company for the Half Year Ended On September 30, 2026

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript